Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$161.01 - $317.85 $1.13 Million - $2.24 Million
7,048 Added 13.66%
58,632 $18.6 Million
Q3 2023

Nov 09, 2023

BUY
$164.66 - $218.08 $1.2 Million - $1.59 Million
7,282 Added 16.44%
51,584 $8.72 Million
Q2 2023

Aug 14, 2023

SELL
$176.32 - $240.22 $4.92 Million - $6.7 Million
-27,884 Reduced 38.63%
44,302 $9.61 Million
Q1 2023

May 15, 2023

SELL
$161.33 - $204.36 $134,387 - $170,231
-833 Reduced 1.14%
72,186 $13.1 Million
Q4 2022

Feb 13, 2023

BUY
$191.53 - $236.82 $514,832 - $636,572
2,688 Added 3.82%
73,019 $14.3 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $2.49 Million - $5.58 Million
20,126 Added 40.09%
70,331 $15.8 Million
Q2 2022

Aug 11, 2022

BUY
$93.97 - $143.33 $515,613 - $786,451
5,487 Added 12.27%
50,205 $6.35 Million
Q1 2022

May 13, 2022

SELL
$98.9 - $132.37 $131,042 - $175,390
-1,325 Reduced 2.88%
44,718 $5.67 Million
Q4 2021

Feb 11, 2022

SELL
$110.64 - $159.4 $113,406 - $163,385
-1,025 Reduced 2.18%
46,043 $6.03 Million
Q3 2021

Nov 04, 2021

SELL
$101.2 - $125.87 $440,422 - $547,786
-4,352 Reduced 8.46%
47,068 $5.76 Million
Q2 2021

Aug 11, 2021

BUY
$107.45 - $135.95 $356,304 - $450,810
3,316 Added 6.89%
51,420 $5.86 Million
Q1 2021

May 13, 2021

SELL
$95.46 - $133.08 $3 Million - $4.18 Million
-31,375 Reduced 39.48%
48,104 $5.78 Million
Q4 2020

Feb 16, 2021

BUY
$75.23 - $109.23 $332,290 - $482,468
4,417 Added 5.88%
79,479 $8.08 Million
Q3 2020

Nov 12, 2020

BUY
$71.31 - $109.74 $53,767 - $82,743
754 Added 1.01%
75,062 $5.8 Million
Q2 2020

Aug 13, 2020

SELL
$62.14 - $117.21 $179,584 - $338,736
-2,890 Reduced 3.74%
74,308 $8.28 Million
Q1 2020

May 14, 2020

SELL
$60.41 - $115.92 $270,757 - $519,553
-4,482 Reduced 5.49%
77,198 $5.56 Million
Q4 2019

Feb 14, 2020

BUY
$11.44 - $123.99 $347,981 - $3.77 Million
30,418 Added 59.34%
81,680 $6.15 Million
Q3 2019

Nov 14, 2019

BUY
$16.05 - $27.35 $822,755 - $1.4 Million
51,262 New
51,262 $834,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.